← Back to Clinical Trials
Recruiting NCT06753045

NCT06753045 Health Electronic Assessment of Risks and Trends Using Biometric Equipment and Technology

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06753045
Status Recruiting
Phase
Sponsor Tulane University
Condition Heart Diseases
Study Type OBSERVATIONAL
Enrollment 10,000 participants
Start Date 2024-10-08
Primary Completion 2027-10

Trial Parameters

Condition Heart Diseases
Sponsor Tulane University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 10,000
Sex ALL
Min Age 18 Years
Max Age 120 Years
Start Date 2024-10-08
Completion 2027-10
Interventions
Smartwatch

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This is a phase 0, non-interventional, longitudinal, electronic data capture (EDC) study to facilitate the HEARTBEAT Study project has set out to explore the potential use of smartwatches in collecting and analyzing biometric data to improve the detection, identification, and understanding of cardiovascular diseases and related conditions by SAMSUNG and Tulane. The study will include up to ten thousand adult subjects tasked with wearing a smartwatch to collect digital biomarker data over a 1 year period. Concurrent to smartwatch data collection, subjects will be instructed to complete questionnaires via the Huma Decentralized Clinical Trials (HUMADCT) platform. There are no investigational drugs or interventions administered as part of this study.

Eligibility Criteria

Inclusion Criteria: * Patients with at least one cardiovascular disease (heart failure, cardiac arrhythmias, chronic kidney disease, coronary artery disease, history of stroke/Transient Ischemic Attack (TIA), or diabetes mellitus). * Patients visiting a primary care provider for any reason without any of the previously mentioned cardiovascular diseases. (Healthy cohort, limited up to 500 patients throughout the study). Exclusion Criteria: * Participants who cannot read, speak, and/or understand English. * Participants with cognitive impairments who are unable to give informed consent or sign their HIPAA form. * Participants with cognitive impairments affecting their ability to be compliant with wearing and maintaining wearable devices. * Participants who are pregnant. * Participants with tattoos, scars, or skin adhesions that would not allow for Photoplethysmography (PPG) recordings to be collected from a wrist-worn device. * Participants with neurological disorders that may interfere

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology